| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. | Cancer Res | 2009 | 3.10 |
| 2 | Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability. | Mol Cancer Ther | 2010 | 1.06 |
| 3 | Potent inhibitors of HIV-1 integrase display a two-step, slow-binding inhibition mechanism which is absent in a drug-resistant T66I/M154I mutant. | Biochemistry | 2009 | 0.97 |